PGIM India Healthcare IDCW Reinvest Direct Plan
SIP amount
Min. ₹1,000
Lumpsum amount
Min. ₹5,000

PGIM India Healthcare IDCW Reinvest Direct Plan

NAV
₹10.2500
-0.68%
(31 Jul)
AUM
112 Cr
TER
0.66%
Risk
Very High Risk
Insights
No insights found for this fund
Compare with other fund
1Y
-8.4%
-8.4%
-8.4%
-9.8%
NA
3Y
+34.8%
+34.8%
+34.8%
+34.4%
NA
5Y
+31.2%
+31.2%
+31.2%
+29.4%
NA
ALL
+12.0%
+12.0%
+12.0%
+16.7%
+1.5%
VOL
20.3%
20.3%
20.3%
20.3%
15.0%
TER
0.8%
0.8%
0.8%
0.9%
0.7%
AUM
₹5,427 Cr
₹5,427 Cr
₹5,427 Cr
₹1,439 Cr
₹112 Cr
INFO
0.59
0.59
0.59
0.82
0.10
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
PGIM India Healthcare IDCW Reinvest (DR)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 30th Jun
Top holdings
Sun Pharmaceuticals Industries Ltd
12.4%
Divi's Laboratories Ltd
8.6%
Max Healthcare Institute Ltd Ordinary Shares
7.9%
Dr Reddy's Laboratories Ltd
6.3%
Aster DM Healthcare Ltd Ordinary Shares
5.4%
Mankind Pharma Ltd
4.7%
Torrent Pharmaceuticals Ltd
4.1%
Abbott India Ltd
3.8%
Krishna Institute of Medical Sciences Ltd
3.5%
Ajanta Pharma Ltd
3.3%
Top industry exposure
Healthcare
88.4%
Financial Services
6.1%
Basic Materials
2.5%
Other information
Minimum SIP
₹1,000
Minimum lumpsum
₹5,000
Additional lumpsum
₹1,000
Portfolio turnover
7%
Lock-in period
-
Exit load
• 0.5% for redemption within 90 days
Fund objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns
Fund manager(s)
Puneet Pal
Anandha Padmanabhan Anjeneyan
Utsav Mehta
Vivek Sharma

FAQs